This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20160309 PLA call"
Jump to navigation
Jump to search
| Line 135: | Line 135: | ||
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
| − | *[[ | + | *[[20160323 PLA call]] |
|} | |} | ||
© 2016 Health Level Seven® International. All rights reserved | © 2016 Health Level Seven® International. All rights reserved | ||
Latest revision as of 15:02, 23 March 2016
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
| HL7 PLA Call Minutes Location: Phone: +1 770-657-9270, Participant Code: 985371, |
Date: 2016-03-09 Time: 2PM | ||
| Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
| Attendee | Name
| ||
| x | Calvin Beebe | ||
| Woody Beeler | |||
| Lorraine Constable | |||
| Bo Dagnall | |||
| Jean Duteau, | |||
| Rick Haddorff | |||
| x | Tony Julian | ||
| Paul Knapp | |||
| Regrets | Austin Kreisler, | ||
| Lynn Laakso | |||
| x | Mary Kay McDaniel | ||
| Brian Pech | |||
| John Roberts | |||
| Andy Stechishin | |||
| x | Wayne Kubick
| ||
| no quorum definition | |||
Agenda
Agenda review
- Notes of 20160224_PLA_call review
- Action items
- Determine which V2 publishing call that PLA can attend to discuss what additions/tweaks will need to be made to the Publishing M&C
- Mary Kay to investigate if the SOA project to create a planning guide is a new product family type
- Mary Kay to send powerpoint for V2 methodology to Tony to take to InM
- Discussion topics
- Finish building out what CDA will look like
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
- Mary Kay asks Calvin to look at CDA presentation that we started to build it out further. Group goes through and Mary Kay makes edits. Link to edited document:
- Question about FHIR: will they template? Calvin: they use profiles using the same kind of tools as templating. Logically it is doing the same sort of things, although adds extensions more than we do. *Mary Kay: there's a dichotomy in attempting to achieve interoperability when we have so many ways of doing the same thing; but there's no way that says this is the absolute standard way it should be done. Calvin: you have to have something like the ONC stating what it has to be. It would be a realm-based governance issue. Discussion over complexities in the industry perpetuating complications in IGs. CDA has become the RIM for IGs. In the future, what should the CDA vision be?
- Will continue with updates to presentation next time
- Adjourned at 3:00 pm
Meeting Outcomes
| Actions
|
| Next Meeting/Preliminary Agenda Items |
© 2016 Health Level Seven® International. All rights reserved
